Catalyst Edge · Scanner · Tickers · SNY
CATALYST DOSSIER · UPDATED 2026-11-05

$SNY

biotech · convergence -6 · conviction WATCH
Convergence Score
-6
Conviction
WATCH
Signals Firing
4
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $SNY?

SNY -6 WATCH biotech

Quantitative

  • Convergence score: -6 (4 signals firing YoY)

Catalysts

  • Clinical trial milestone: A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic Cardi
  • Clinical trial milestone: A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

Risks

  • Position-sizing discipline: Conviction WATCH (-6 score) — size accordingly; no specific catalyst-fade risk flagged

Bear case

  • Multiple compression: If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis

Sympathy basket (cerebro)

  • PLTK via tech r=+0.91 sympathetic (score 22)
  • EPAM via tech r=+0.91 sympathetic (score 8)
  • DIOD via semis r=+0.78 sympathetic (score 14)
  • NVDA via semis r=+0.78 sympathetic (score 12)
  • CHTR via comms r=+0.77 sympathetic (score 20)
  • VISN via comms r=+0.77 sympathetic (score 8)

Signals Firing

clinicalauto_macro_adp_payrollsauto_macro_durable_goodsauto_macro_fx_rates
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Sympathy Basket

Tickers Catalyst Edge tracks as moving with this name. Cross-correlation derived from sector + score-cohort proximity.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

You came here for SNY. You found it after it moved, the same way everyone else did.

$99 once — every ticker on this site ranked before the open.

Review the methodology and limitations and the dated audit. An intraday price touch is not trading profit.

  1. Click Become a Founding Member below.
  2. Pay $99 once — not monthly, not ever again.
  3. You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.
Become a Founding Member — $99 once

One payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →

Optional product-learning preferences